Zenouzi, Roman

Alterations of the bile microbiome in primary sclerosing cholangitis

Liwinski, T., Zenouzi, R., John, C., Ehlken, H., Rühlemann, M. C., Bang, C., Groth, S., Lieb, W., Kantowski, M., Andersen, N., et al. (2020) · Gut

Liver Diseases and ImmunityGut microbiota and health

Cited by 149

Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis

Kummen, M., Thingholm, L. B., Rühlemann, M. C., Holm, K., Hansen, S. H., Moitinho-Silva, L., Liwinski, T., Zenouzi, R., Storm-Larsen, C., Midttun, Ø., et al. (2021) · Gastroenterology

Gut microbiota and healthLiver Diseases and Immunity

Cited by 129

Monocytes as Potential Mediators of Pathogen‐Induced T‐Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)

Kunzmann, L. K., Schoknecht, T., Poch, T., Henze, L., Stein, S., Kriz, M., Grewe, I., Preti, M., Hartl, J., Pannicke, N., et al. (2020) · Hepatology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 93

Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis

Zenouzi, R., Weismüller, T. J., Hübener, P., Schulze, K., Bubenheim, M., Pannicke, N., Weiler–Normann, C., Lenzen, H., Manns, M. P., Lohse, A. W., et al. (2014) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityHepatocellular Carcinoma Treatment and Prognosis

Cited by 86

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis

Peiseler, M., Reiners, D., Pinnschmidt, H. O., Sebode, M., Jung, F., Hartl, J., Zenouzi, R., Ehlken, H., Groth, S., Schachschal, G., et al. (2018) · PLOS ONE

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 17